<DOC>
	<DOCNO>NCT01087801</DOCNO>
	<brief_summary>The follow study hypothesis : - Secretin administration compare placebo result statistically significantly great percentage collect fluid sample predominantly exocrine pancreas origin sample duodenal aspirate . - Secretin administration compare placebo result statistically significantly great percentage collect fluid sample meet minimum specification use indicated laboratory test DNA mutational analysis .</brief_summary>
	<brief_title>A Study Synthetic Human Secretin ( ChiRhoStim® ) Administered Intravenously Stimulate Exocrine Pancreas Fluid Secretion Collection Via Endoscope Laboratory Analysis DNA Markers</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Diseases</mesh_term>
	<mesh_term>Secretin</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<criteria>1 . Documented suspected diagnosis chronic pancreatitis suspect diagnosis pancreatic cancer . 2 . Undergoing Endoscopic Procedure . 3 . Age ≥ 18 year . 4 . Willing able sign inform consent , meet IRB guideline . 5 . Willing able meet study requirement obligation . 1 . Ongoing , active pancreatitis time procedure . 2 . Known adverse reaction secretin . 3 . Recent ( within one month ) use medication potentially cause pancreatitis , metronidazole , tetracycline , sulfonamide . 4 . Use anticholinergic medication within 7 day study . 5 . Pregnant woman , nurse mother , woman childbearing potential employ appropriate contraception . Acceptable method birth control : intrauterine device , implantable progesterone device , progesterone intramuscular injection , oral contraceptive ( start least one month prior Visit 1 continue duration trial ) , contraceptive patch , condom spermicide abstinence . 6 . Any medical condition judgment Principal Investigator make participation patient study medically unwarranted . 7 . Known complete obstruction pancreatic duct . 8 . Patients receive investigational product/drug device within 30 day prior Visit 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Genetic End Marker</keyword>
</DOC>